Published in J Clin Microbiol on September 01, 1998
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Importance of sample preparation for molecular diagnosis of lyme borreliosis from urine. J Clin Microbiol (2002) 1.16
The role of DNA amplification technology in the diagnosis of infectious diseases. CMAJ (2000) 1.14
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One (2013) 1.02
Lyme borreliosis and skin. Indian J Dermatol (2013) 0.96
Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR. J Clin Microbiol (2001) 0.92
Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol (2005) 0.91
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. J Transl Med (2015) 0.76
Michel's Transport Medium as an Alternative to Liquid Nitrogen for PCR Analysis of Skin Biopsy Specimens. Dermatopathology (Basel) (2014) 0.75
Published data do not support the notion that Borrelia valaisiana is human pathogenic. Infection (2017) 0.75
Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. Ger Med Sci (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Antigenic variability of Borrelia burgdorferi. Ann N Y Acad Sci (1988) 5.02
PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol (1991) 4.65
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07
Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol (1995) 3.59
A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis (1989) 3.53
Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J Clin Microbiol (1993) 3.26
The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol (1987) 3.09
Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol (1995) 2.77
Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol (1991) 2.71
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Detection of Borrelia burgdorferi in patients with Lyme disease by the polymerase chain reaction. J Clin Pathol (1991) 2.23
Standardization of medium for culturing Lyme disease spirochetes. J Clin Microbiol (1993) 2.19
Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction. Am J Pathol (1990) 2.18
Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol (1992) 2.12
Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. Infect Immun (1992) 2.10
PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies. PCR Methods Appl (1991) 1.95
Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med (1995) 1.74
PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology (1992) 1.69
Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans. Am J Clin Pathol (1993) 1.64
Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. Infect Immun (1991) 1.63
Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol (1992) 1.54
Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis (1994) 1.50
Identification and characterization of a surface-exposed, 66-kilodalton protein from Borrelia burgdorferi. Infect Immun (1995) 1.41
The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis (1991) 1.26
Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease. J Clin Microbiol (1991) 1.26
Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr (1993) 1.22
Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol (1994) 1.18
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis (1996) 1.17
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol (1994) 1.16
An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol (1997) 1.15
Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol (1996) 1.14
Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis (1995) 1.13
Evaluation of the detection of Borrelia burgdorferi DNA in urine samples by polymerase chain reaction. Infection (1996) 1.09
Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J Clin Microbiol (1994) 1.08
Polymerase chain reaction amplification of culture supernatants for rapid detection of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis (1993) 1.06
Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J Cutan Pathol (1993) 1.05
Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol (1994) 1.04
Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection (1997) 1.04
Lyme borreliosis--problems of serological diagnosis. Infection (1997) 0.99
Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol (1994) 0.98
Clinical pathologic correlations of Lyme disease. Rev Infect Dis (1989) 0.96
Persistence of Borrelia burgdorferi sensu lato in resolved erythema migrans lesions. Clin Infect Dis (1995) 0.93
[Lyme borreliosis in South Germany. Epidemiologic data on the incidence of cases and on the epidemiology of ticks (Ixodes ricinus) carrying Borrelia burgdorferi]. Dtsch Med Wochenschr (1987) 0.92
No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol (1995) 0.91
No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch Dermatol (1995) 0.84
Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Acta Derm Venereol Suppl (Stockh) (1985) 0.82
Polymerase chain reaction analysis of DNA from paraffin-embedded tissue. Methods Mol Biol (1993) 0.82
Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis. Infection (1996) 0.77
Bacterial phylogeny based on comparative sequence analysis. Electrophoresis (1998) 5.59
Correlation between structure and pathogenicity of potato spindle tuber viroid (PSTV). EMBO J (1985) 2.63
Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods (1998) 2.31
Conformational transitions in viroids and virusoids: comparison of results from energy minimization algorithm and from experimental data. J Biomol Struct Dyn (1984) 2.14
No .NO from NO synthase. Proc Natl Acad Sci U S A (1996) 2.14
Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem (2000) 2.09
Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol (1999) 1.66
Molecular and immunological characterization of a novel polymorphic lipoprotein of Borrelia burgdorferi. Infect Immun (1993) 1.64
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet (1997) 1.63
Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol (1984) 1.59
The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass. J Thorac Cardiovasc Surg (2003) 1.52
Rapid diagnosis of tick-borne encephalitis by means of enzyme linked immunosorbent assay. J Gen Virol (1979) 1.51
Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney, and heart. Proc Natl Acad Sci U S A (1994) 1.44
Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. Circ Res (1997) 1.41
[An increased risk of kinesitherapy in silent myocardial ischemia?]. Dtsch Med Wochenschr (1993) 1.38
The role of polar and hydrophobic interactions for the molecular packing of type I collagen: a three-dimensional evaluation of the amino acid sequence. J Mol Biol (1978) 1.37
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine (1990) 1.35
Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Mol Pharmacol (2001) 1.33
Physical activity and gestational weight gain: a meta-analysis of intervention trials. BJOG (2010) 1.29
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials (2005) 1.26
Neuronal distribution and functional characterization of the calcium channel alpha2delta-2 subunit. Eur J Neurosci (2000) 1.25
The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J Virol (1997) 1.24
Epidemiological analysis of Neisseria gonorrhoeae in the Federal Republic of Germany by auxotyping and serological classification using monoclonal antibodies. Genitourin Med (1986) 1.23
Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol (1994) 1.18
Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol (1981) 1.17
Studies in man with cold-recombinant influenza virus (H1N1) live vaccines. J Med Virol (1980) 1.16
Phylogenetic relationships of Bacteria based on comparative sequence analysis of elongation factor Tu and ATP-synthase beta-subunit genes. Antonie Van Leeuwenhoek (1994) 1.13
The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. EMBO J (1996) 1.12
Biosynthesis, secretion and extracellular localization of anchorin CII, a collagen-binding protein of the calpactin family. EMBO J (1988) 1.09
Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J Colloid Interface Sci (2004) 1.07
Expression of T- and L-type calcium channel mRNA in murine sinoatrial node. FEBS Lett (2000) 1.06
Dynamics and interactions of viroids. J Biomol Struct Dyn (1983) 1.04
The amino side of the C-terminus determines fast inactivation of the T-type calcium channel alpha1G. J Physiol (2001) 1.04
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet (1992) 1.04
Aspartate residues of the Glu-Glu-Asp-Asp (EEDD) pore locus control selectivity and permeation of the T-type Ca(2+) channel alpha(1G). J Biol Chem (2001) 1.03
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis (2000) 1.02
Screening for possible failure of herpes simplex virus PCR in cerebrospinal fluid for the diagnosis of herpes simplex encephalitis. J Med Virol (2001) 1.02
Agreement in endpoints from circadian rhythmometry on healthy humans beings living on different continents. Experientia (1969) 1.01
Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers. Neuropharmacology (2000) 1.01
Gating of the expressed Cav3.1 calcium channel. FEBS Lett (2002) 0.98
Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis. Pflugers Arch (1996) 0.96
Ciliary neurotrophic factor blocks rod photoreceptor differentiation from postmitotic precursor cells in vitro. Cell Tissue Res (1998) 0.95
[Early diagnosis of tick-borne encephalitis in the hemagglutination-inhibition-test by treatment of serum with 2 mercaptoethanol]. Zentralbl Bakteriol Orig A (1971) 0.95
Immunoglobulins to tick-borne encephalitis in the cerebrospinal fluid of man. J Med Virol (1979) 0.95
Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol (1980) 0.94
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis (2006) 0.94
Intracellular Ca2+ inactivates L-type Ca2+ channels with a Hill coefficient of approximately 1 and an inhibition constant of approximately 4 microM by reducing channel's open probability. Biophys J (1997) 0.94
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
Identification and functional characterization of a calcium channel gamma subunit. Pflugers Arch (1997) 0.93
The role of subunit composition on prepulse facilitation of the cardiac L-type calcium channel. FEBS Lett (1999) 0.93
Anaerobic curved rods in genital samples of women. Performance of different selective media, comparison of detection by microscopy and culture studies, and recovery from different sampling sites. Scand J Urol Nephrol Suppl (1984) 0.92
[Incidence of genital chlamydia and mycoplasma infections in women]. Z Hautkr (1984) 0.92
Structural model of the collagen-like region of C1q comprising the kink region and the fibre-like packing of the six triple helices. J Mol Biol (1985) 0.91
Comparative analysis of the sequences of the three collagen chains alpha 1(I), alpha 2 and alpha 1(III) Functional and genetic aspects. J Mol Biol (1980) 0.91
Construction of a model for the aggregation and cross-linking region (7S domain) of type IV collagen based upon an evaluation of the primary structure of the alpha 1 and alpha 2 chains in this region. Eur J Biochem (1987) 0.90
Pigmented Xerodermoid: first report of a family. Bull Cancer (1978) 0.90
Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) (1999) 0.90
Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel. Mol Pharmacol (1997) 0.90
Subcutaneous oleomas induced by self-injection of sesame seed oil for muscle augmentation. J Am Acad Dermatol (2000) 0.90
Cyclosporins--new analogues by precursor directed biosynthesis. J Antibiot (Tokyo) (1989) 0.89
Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity. Biochem J (1999) 0.89
Low voltage activated calcium channels: from genes to function. Gen Physiol Biophys (2000) 0.89
Phytophotodermatitis due to Ruta graveolens applied as protection against evil spells. Contact Dermatitis (1999) 0.88
[Liver transplantation in the GDR]. Khirurgiia (Mosk) (1981) 0.88
Calcium blocks selectively the EOG-light peak. Doc Ophthalmol (1985) 0.87
Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase. J Biol Chem (1998) 0.87
Prenatal diagnosis of campomelic dysplasia by ultrasonography. Prenat Diagn (1985) 0.87
Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J Biol Chem (2000) 0.87
ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.87
Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms. J Physiol (1999) 0.87
[Demonstration of antibodies in sera of wild animals for the detection of foci of tick-borne encephalitis (TBE) virus in Lower Austria]. Zentralbl Bakteriol Orig (1968) 0.87
Intermittent sequential compression of the lower limbs prevents venous stasis in laparoscopic and conventional colorectal surgery. Dis Colon Rectum (1997) 0.86
[Retinal detachment: extent and occurrence of reattachment using preoperative immobilization]. Klin Monbl Augenheilkd (1973) 0.86
Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor. J Med Chem (1999) 0.86
Gating of the expressed T-type Cav3.1 calcium channels is modulated by Ca2+. Acta Physiol (Oxf) (2006) 0.86
Functional coupling between 'R-type' Ca2+ channels and insulin secretion in the insulinoma cell line INS-1. Eur J Biochem (2001) 0.85
Absence of modulation of the expressed calcium channel alpha1G subunit by alpha2delta subunits. J Physiol (1999) 0.84
Essential role of the beta subunit in modulation of C-class L-type Ca2+ channels by intracellular pH. FEBS Lett (1997) 0.83
[Experimental infection with tick-borne encephalitis (TBE) virus of some European mammals]. Zentralbl Bakteriol Orig (1968) 0.83
Intensified conventional insulin therapy for the pregnant diabetic patient. Obstet Gynecol (1984) 0.83
Effect of wave exposure dynamics on gut content mass and growth of young-of-the-year fishes in the littoral zone of lakes. J Fish Biol (2010) 0.82
Microbial biotransformation products of cyclosporin A. J Antibiot (Tokyo) (1996) 0.82
Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels. J Pharmacol Exp Ther (1999) 0.82
Evidence of hepatitis C virus in cervical smears. J Infect (1999) 0.82
Prominent T cell response to a selectively in vivo expressed Borrelia burgdorferi outer surface protein (pG) in patients with Lyme disease. Eur J Immunol (2001) 0.82
Blood coagulation induced by the venom of Bothrops atrox. 1. Identification, purification, and properties of a prothrombin activator. Biochemistry (1987) 0.82
Flow cytometry as a new method for the measurement of electrophoretic mobility of erythrocytes using membrane charge staining by fluoresceinated polycations. J Histochem Cytochem (1979) 0.81
Amniotic fluid glucose values in normal and abnormal pregnancies. Obstet Gynecol (1985) 0.81
[Eyelid and eyeball damage in facial injuries]. Fortschr Kiefer Gesichtschir (1966) 0.81
Fetal insulin balance: gestational diabetes and postpartal screening. Obstet Gynecol (1984) 0.81
Onychogryphosis in elderly persons: an indicator of long-standing poor nursing care? Report of one case and review of the literature. Cutis (2001) 0.81
[Virtual microscopy and digital pathology]. Pathologe (2006) 0.81
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J Med Virol (1994) 0.80
[A strain of "Marburg virus" (Rhabdovirus simiae) pathogenic to mice]. Arch Gesamte Virusforsch (1970) 0.80
The assessment of immunity against hepatitis B after vaccination. J Biol Stand (1986) 0.80
Prenatal diagnosis of myotonic dystrophy using closely linked flanking markers. J Med Genet (1991) 0.80
Tick-borne encephalitis: a simple method for detection of antibody production in the brain. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.80
Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis (1992) 0.80